Joey Azofeifa

BioFrontiers Institute and IQ Biology alum, Joey Azofeifa (Arpeggio Bio), Raises $3.2 Million in Seed Funding and is Named to the 2020 Forbes 30 Under 30 List in Healthcare

Jan. 15, 2020

Arpeggio Bio, a preclinical company whose technology provides a mechanistic understanding of how drugs work, today announced that it has closed a $3.2 million seed financing round, which was oversubscribed by over $2 million. Funding will support the ongoing development of a nascent RNA drug screen. “We’re excited to have...

Participants of BizWest's CEO Roundtable on Life Sciences in Boulder are, from left, Misha Plam, Ron Squarer, David Kerr, William Marshall, Chris Shapard, Jennifer Jones, Tin Tin Su, Pawel Fludzinski, Amy Beckley, Tom Cech, Becky Potts, Kyle Lefkoff, Tom Hertzberg, Jonathan Vaught, Marvin Caruthers, Not pictured: Brynmor Reese. BizWest/Jensen Werley.

Boulder’s bioscience industry growing to critical mass

April 18, 2018

After years of companies being sold off or growing and relocating, Boulder’s life-sciences sector is showing signs of reaching critical mass. Companies such as Clovis Oncology Inc. (Nasdaq: CLVS), SomaLogic Inc., Array Biopharma Inc. (Nasdaq: ARRY) and miRagen Therapeutics Inc. (Nasdaq: MGEN) are showing that homegrown businesses can continue to...